Display options
Cite
Nasli-Esfahani E, Peimani M, Rambod C, et al. Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran. Iran J Public Health. 2014;43(6):713-21
Nasli-Esfahani, E., Peimani, M., Rambod, C., Omidvar, M., & Larijani, B. (2014). Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran. Iranian journal of public health, 43(6), 713-21.
Nasli-Esfahani, Ensieh, et al. "Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran." Iranian journal of public health vol. 43,6 (2014): 713-21.
Nasli-Esfahani E, Peimani M, Rambod C, Omidvar M, Larijani B. Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran. Iran J Public Health. 2014 Jun;43(6):713-21. PMID: 26110142; PMCID: PMC4475590.
Copy Download .nbib Format: NLM
Share it on

Iran J Public Health. 2014 Jun;43(6):713-21.

Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran.

Iranian journal of public health

Ensieh Nasli-Esfahani, Maryam Peimani, Camelia Rambod, Maryam Omidvar, Bagher Larijani

Affiliations

  1. 1. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences , Tehran, Iran.
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences , Tehran, Iran.

PMID: 26110142 PMCID: PMC4475590

Abstract

Development of evidence-based clinical guidelines to raising standards of medical care in diabetes is a core element of coping with the global diabetes epidemic. The purpose of this study was to develop a systematic clinical diabetes guideline from the latest scientific evidences and also to localize its recommendations according to regional and cultural needs of our society. Searches were conducted using NICE, SIGN, WDPCP, IDF, JDC, ADA, AACE, ICSI, CDA, AMDA, IDC, NyDoH guidelines which were examined and criticized and scored using Agree method. Guidelines which got higher score in some important areas of Agree scale including: rigor of development, clarity and comprehensiveness of the recommendations and applicability, especially in the climatic conditions of our country were selected. The existing recommendations were extracted by committee members and supporting evidences of each recommendation were determined based on the sources listed in the clinical guideline. Recommendations grading were classified from grade A to D based on the quality of their supporting evidences (BEL1-5). This guideline covered all areas related to diabetes including screening and diagnosis, lifestyle modification and patient education, management, complications and hypoglycemia. Regarding capacities of this guideline and lack of comprehensive and updated guidelines in our country and region, it is suggested that designing a pilot study to implement this Learner-centered guideline and finding its weaknesses can lead to patient care improvement and also propel us towards our goal to design a comprehensive guideline in compliance with regional and national needs in Middle East.

Keywords: Clinical guidelines; Diabetes; Diabetes network; Iran

References

  1. Indian J Endocrinol Metab. 2012 Jul;16(4):499-502 - PubMed
  2. Iran J Public Health. 2012;41(5):66-72 - PubMed
  3. Clin Chem. 2011 Jun;57(6):e1-e47 - PubMed
  4. J R Soc Med. 2010 Apr;103(4):139-47 - PubMed
  5. Implement Sci. 2011 Mar 22;6:26 - PubMed
  6. Diabetes Care. 2008 Jan;31(1):96-8 - PubMed
  7. Diabetes Ther. 2013 Jun;4(1):91-102 - PubMed
  8. Diabetologia. 2012 Jun;55(6):1577-96 - PubMed
  9. Implement Sci. 2009 Aug 12;4:54 - PubMed
  10. J Korean Med Sci. 2012 Aug;27(8):876-82 - PubMed
  11. Diabetes Care. 1998 Sep;21(9):1391-6 - PubMed
  12. Virtual Mentor. 2011 Jan 01;13(1):36-41 - PubMed
  13. Diabetes Care. 2012 Jan;35(1):87-91 - PubMed
  14. Endocr Pract. 2011 Mar-Apr;17 Suppl 2:1-53 - PubMed
  15. Diabetologia. 2009 Aug;52(8):1520-7 - PubMed
  16. JAMA. 2013 Sep 4;310(9):948-59 - PubMed
  17. Ann Intern Med. 2012 Jan 3;156(1 Pt 1):27-36 - PubMed
  18. Arch Iran Med. 2009 Sep;12(5):492-5 - PubMed
  19. Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72 - PubMed
  20. J Am Med Dir Assoc. 2013 Nov;14(11):851.e7-15 - PubMed
  21. Singapore Med J. 2008 Jul;49(7):571-6 - PubMed
  22. Iran J Public Health. 2013 Jan 01;42(Supple1):113-8 - PubMed
  23. East Mediterr Health J. 2003 Sep-Nov;9(5-6):1122-7 - PubMed
  24. PLoS One. 2011;6(10):e26725 - PubMed
  25. Diabetes Care. 2013 Aug;36 Suppl 2:S139-44 - PubMed
  26. Proc Am Thorac Soc. 2012 Dec;9(5):219-24 - PubMed
  27. Health Res Policy Syst. 2010 Mar 02;8:6 - PubMed
  28. Med Care. 2014 Mar;52 Suppl 3:S92-S100 - PubMed
  29. Iran J Public Health. 2012;41(8):50-5 - PubMed
  30. PLoS One. 2013;8(4):e58625 - PubMed
  31. Lancet. 2007 Dec 8;370(9603):1929-38 - PubMed

Publication Types